IMMU - Immunomedics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $98.64. This is a potential upside of $10.78 (12.27%) from yesterday's end of day stock price of $87.86.

Immunomedics's activity chart (see below) currently has 101 price targets and 61 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 96.53% with an average time for these price targets to be met of 213.42 days.

Most recent stock forecast was given by CHRIS HOWERTON from JEFFERIES on 15-Sep-2020. First documented stock forecast 29-Jul-2015.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$55

5 years 3 months 4 days ago
(15-Sep-2020)

5/6 (83.33%)

$11.69 (26.99%)

66

Hold

$55

5 years 3 months 5 days ago
(14-Sep-2020)

6/6 (100%)

$14.37 (35.37%)

265

Hold

$56

5 years 3 months 5 days ago
(14-Sep-2020)

8/8 (100%)

$14.84 (36.05%)

163

$40

$-47.86 (-54.47%)

$19

5 years 4 months 9 days ago
(10-Aug-2020)

5/5 (100%)

$-0.92 (-2.25%)

252

Buy

$55

$-32.86 (-37.40%)

$45

5 years 4 months 13 days ago
(06-Aug-2020)

9/9 (100%)

$11.82 (27.37%)

107

Show more analysts

Please expand the browser size to see the chart

What is IMMU (Immunomedics) average time for price targets to be met?

On average it took 213.42 days on average for the stock forecasts to be realized with a an average price target met ratio 96.53

Which analyst has the current highest performing score on IMMU (Immunomedics) with a proven track record?

MADHU KUMAR

Which analyst has the most public recommendations on IMMU (Immunomedics)?

Madhu Kumar works at GOLDMAN SACHS and has 8 price targets and 5 ratings on IMMU

Which analyst is the currently most bullish on IMMU (Immunomedics)?

Raghuram Selvaraju with highest potential upside - $0

Which analyst is the currently most reserved on IMMU (Immunomedics)?

Matthew Andrews with lowest potential downside - -$65.86

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?